ACT-541468

· Idorsia

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for ACT-541468, covering 2017-12-11 to 2022-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder [Phase 3]

See pricing